Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
Condition(s):Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:August 14, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:August 14, 2019Completed
Condition(s):Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:August 2, 2018Completed
Condition(s):Metastatic Pancreatic Ductal Adenocarcinoma; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Unresectable Pancreatic Ductal AdenocarcinomaLast Updated:March 26, 2024Recruiting
Condition(s):KRAS P.G12C; Non-small Cell Lung Cancer; Colorectal Cancer; Pancreatic Ductal CarcinomaLast Updated:June 30, 2022Recruiting
Condition(s):Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Arthritis; Hypertension; SepsisLast Updated:April 25, 2017Completed
Condition(s):Biliary Tract Diseases; Stomach Neoplasms; Carcinoma, Pancreatic Ductal; Barrett EsophagusLast Updated:March 10, 2016Unknown status
Condition(s):Diabetes Mellitus, Adult-Onset; Diabetes Complications; Carcinoma, Pancreatic Ductal; Pancreatic NeoplasmLast Updated:November 20, 2017Terminated
Condition(s):Carcinoma, Pancreatic Ductal; Mesothelioma; Ovarian Neoplasms; Carcinoma, Non-Small-Cell LungLast Updated:December 17, 2019Terminated
Condition(s):Pancreatic Adenocarcinoma; Liver MetastasesLast Updated:January 8, 2024Recruiting
Condition(s):Metastatic Solid Tumor CancerLast Updated:February 16, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.